320 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Urinary Bladder Diseases" (320 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
Conditions: Locally Advanced or Metastatic Urothelial Cell Carcinoma;   Urinary Bladder Disease;   Urological Diseases
Interventions: Drug: B-701;   Drug: Docetaxel;   Drug: placebo
2 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Overactive Bladder;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
3 Not yet recruiting 3D HD Versus 2D HD in Cholecystectomy
Conditions: Cholelithiasis;   Gall Bladder Disease
Interventions: Device: 3D HD laparoscopy;   Device: 2D HD laparoscopy
4 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
5 Recruiting Vicinium Treatment for Subjects With High-grade Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Condition: Bladder Cancer
Intervention: Biological: Vicinium
6 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
7 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
8 Recruiting Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC
Condition: Carcinoma of Urinary Bladder, Superficial
Interventions: Device: 40 mg MMC gel;   Other: Standard of care MMC mixed with water;   Device: 80 mg MMC gel
9 Not yet recruiting The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury
Conditions: Spinal Cord Injury;   Neurogenic Bladder
Interventions: Device: Transcutaneous Tibial Nerve Stimulation;   Device: Control
10 Recruiting Comparing Rectus Sheath Catheter to Epidural Post Cystectomy
Conditions: Bladder Cancer;   Postoperative Pain
Interventions: Device: Epidural;   Device: Rectus Sheath Catheters
11 Recruiting Acupuncture on Post-Stroke Overactive Bladder
Condition: Overactive Bladder
Interventions: Other: Traditional Acupuncture;   Other: Placebo Acupuncture;   Other: Usual Care
12 Not yet recruiting A Study of Intravesical Apaziquone as a Surgical Adjuvant in Patient Undergoing TURBT
Condition: Bladder Cancer
Interventions: Drug: Apaziquone;   Other: Placebo
13 Not yet recruiting Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer
Condition: Invasive Bladder Cancer
Interventions: Drug: Pembrolizumab;   Radiation: Radiotherapy
14 Recruiting A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
Condition: Bladder Cancer
Interventions: Drug: Hexaminolevulinate hydrochloride;   Device: KARL STORZ D-Light C PDD Flexible Videoscope System
15 Not yet recruiting Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer
Condition: Urinary Bladder Neoplasms
Interventions: Drug: Gemcitabine;   Drug: Paclitaxel;   Drug: Cisplatin
16 Recruiting Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder
Condition: Urinary Bladder, Overactive
Intervention: Drug: onabotulinumtoxinA
17 Recruiting Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT)
Condition: Bladder Cancer
Interventions: Device: HoLERBT;   Device: cTURBT
18 Recruiting Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)
Conditions: Bladder Cancer;   Melanoma
Interventions: Drug: Nivolumab;   Drug: Nivolumab plus Ipilimumab
19 Not yet recruiting HuMax®-TF-ADC Safety Study in Patients With Solid Tumors
Conditions: Ovary Cancer;   Cervix Cancer;   Endometrium Cancer;   Bladder Cancer;   Prostate Cancer (CRPC);   Esophagus Cancer;   Lung Cancer (NSCLC)
Intervention: Drug: HuMax-TF-ADC
20 Recruiting Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS
Conditions: Interstitial Cystitis;   Painful Bladder Syndrome
Intervention: Device: Posterior Tibial Nerve Stimulation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years